The safety and effectiveness of nafamostat is being assessed in the NEPHRO CRRT registrational trial in 166 patients at up to 14 clinical sites Primary endpoint in the NEPHRO CRRT study is measured ...

For pediatric articles, we queried the PubMed database using the following terms: citrate anticoagulation [title] and continuous; citrate AND continuous; citrate [title] AND continuous AND pediatric; ...

Only authorized citrate-based replacement solution available in the U.S. for use in continuous renal replacement therapy (CRRT) during COVID-19 pandemic Supports need for regional citrate ...

All patients undergoing CRRT while on ECLS between 2005 and 2010 at Seattle Children's Hospital (n = 42) were identified by a retrospective review of a prospectively maintained institutional database.

Study results demonstrate that nafamostat had similar efficacy as citrate, while providing lower toxicity and lower costs to the hospital over standard citrate anticoagulation. A total of 158 patients ...

The Continuous Renal Replacement Therapy Market represents a critical segment within the global healthcare industry, ...

Earnings call Talphera reported a sharp acceleration in patient enrollment for its nafamostat CRRT trial, enrolling 9 patients in 6 weeks—more than doubling total enrollment since May. Cash OpEx ...

Only authorized citrate-based replacement solution available in the U.S. for use in continuous renal replacement therapy (CRRT) during COVID-19 pandemic Supports need for regional citrate ...

Only authorized citrate-based replacement solution available in the U.S. for use in continuous renal replacement therapy (CRRT) during COVID-19 pandemic Supports need for regional citrate ...

Baxter International Inc., a global leader in acute care, has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for Regiocit, the company’s replacement solution ...